Wikidata

(Q62034267)

English

Efficacy, Safety, and Tolerability Study of Apremilast to Treat Early Oligoarticular Psoriatic Arthritis.

clinical trial

In more languages

Statements

short name
FOREMOST (English)
0 references
title
A MULTICENTER, RANDOMIZED, CONTROLLED STUDY TO EVALUATE EFFICACY AND SAFETY OF APREMILAST IN EARLY PSORIATIC ARTHRITIS PATIENTS WITH OLIGOARTHRITIS AND MODERATE DISEASE ACTIVITY: APTITUDE (APremilasT In paTients With oligoarticUlar Psoriatic Arthritis DiseasE) (English)
0 references
sponsor
Celgene
0 references
country
Austria
0 references
Belgium
0 references
Canada
0 references
France
0 references
Germany
0 references
Italy
0 references
Netherlands
0 references
Spain
0 references
United Kingdom
0 references
start time
20 December 2018
0 references
end time
17 July 2020
0 references
number of participants
330
0 references
research intervention
apremilast
0 references
thalidomide
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q62034267&oldid=2148520565"